AzTrials
AzTrials

Hamstring InjuryNCT05343052

Hamstring Injury (HAMIR) Index

An observational study of Hamstring Injury, run by University of Wisconsin, Madison at 5 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators will combine state-of-the-art quantitative imaging, on-field biomechanics, and computational analytics into the largest-of-its-kind study to assess hamstring strain injury (HSI) risk and recovery in elite collegiate football players. Read more about this study

Who is it for?
Ages 18 to 26 yearsHealthy volunteers can take part
Conditions the study is for
Hamstring Injury
What is being tested?
Patient Reported Outcomes Surveys, Clinical Assessments and Biomechanical and Neuromuscular Assessments
Type of treatment
Medical device
How many people
699 participants
Where
5 sitesUnited States
Study dates
25 Apr 2022to 5 Jun 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 26 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Student-athlete rostered on the varsity football team of participating institutions between 5/1/2022-6/30/2025 (study period)

Who may be able to join

  • Student-athlete rostered on the varsity football team of participating institutions between 5/1/2022-6/30/2025 (study period)

Who cannot join

  • History of malignant disease
  • Contraindication to MRI

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

United States5 sites
  • Indiana University

    Bloomington, Indiana, 47405

  • University of North Carolina - Chapel Hill

    Chapel Hill, North Carolina, 27514

  • University of Wisconsin - Madison

    Madison, Wisconsin, 53705

  • Notre Dame University

    Notre Dame, Indiana, 46556

  • Brigham Young University

    Provo, Utah, 84602

Other trials in United States

About this study

Official title: Hamstring Injury (HAMIR) Index: A Framework for Injury Mitigations Strategies Through Innovative Imaging, Biomechanics, and Data Analytics

The investigators will combine state-of-the-art quantitative imaging, on-field biomechanics, and computational analytics into the largest-of-its-kind study to assess hamstring strain injury (HSI) risk and recovery in elite collegiate football players. The study will take place over 3 years and enroll up to 560 student athletes from Division I (D1) teams: University of Wisconsin-Madison, Brigham Young University and the University of North Carolina-Chapel Hill.

Read the detailed description

The current approach to assess hamstring strain injury (HSI) risk and recovery is suboptimal. Many player-games are lost in American Football due to the lack of a clear understanding of the risk factors for HSI and the absence of effective methods to minimize re-injury.

The investigators propose that the key issues are: 1) every athlete is unique; therefore, a "one-size-fits-all" approach to HSI risk assessment will not work; 2) clinicians have limited relevant information on the potential injury risk for a specific athlete; 3) current methods to assess the extent of injury in a specific athlete are largely qualitative, limiting the ability to determine re-injury risk; and 4) current use of biologic injections is common, yet studies to quantify their effects are lacking. In this study, the investigators will address these four critical barriers by combining state-of-the-art quantitative imaging, on-field biomechanics, and computational analytics into the largest-of-its-kind study of elite collegiate football players.

The study will be conducted in 4 Division I collegiate men's football teams over a 3-year period. All student-athletes enrolled in this study will complete preseason hamstring strength testing, inertial measurement units (IMU)-based sprinting biomechanics, and undergo baseline magnetic resonance imaging (MRI). Student-athletes will be monitored by athletic trainers throughout the school year, who will record injuries and participation (e.g., time in practice, game).

Student-athletes who sustain an HSI will undergo a clinical assessment at the time of injury along with an MRI examination. Following completion of a rehabilitation program, hamstring strength will be re-evaluated and imaging will be repeated, along with performance measurements.

This study will provide the most detailed understanding of the physiological causes and effects of HSI, advancing our understanding of the processes affecting muscle function and improving our ability to evaluate, treat, and prevent HSI. This study represents what will be the largest, most quantitative prospective cohort study ever into HSI. Data gathered as part of this study will be used to develop a quantitative Hamstring Injury (HAMIR) index such that the medical and scientific communities can identify an individual athlete's propensity for HSI, and, more importantly, identify targets for injury mitigation, thereby reducing the global burden of HSI.

Aim 1. Develop a risk prediction model for HSI based on morphological, architectural, biomechanical and clinical factors in National Collegiate Athletic Association (NCAA) D1 college football players. The goal is to test the predictive capacity of innovative measures of risk for initial HSI in the largest prospective cohort study ever conducted in HSI. The outcome will be the establishment of a quantitative HAMIR index that is based on multiple athlete-specific measures. This aim will also identify potential future targets for injury risk mitigation and prophylactic strategies.

Aim 2. Develop a risk prediction model for recurrent HSI based on morphological, architectural, biomechanical and clinical factors (identified in Aim 1) in NCAA D1 college football players by completing the largest ever analysis of re-injury data. The investigators will track players who sustain an HSI, both immediately after injury and longitudinally. Quantification of injury metrics (e.g., volume of initial edema and volume, shape and location of long-term scar) will be incorporated into the analytics framework to develop a new "re-injury" HAMIR index. Similar to Aim 1, this aim will identify potential future targets for re-injury risk mitigation and prophylactic approaches.

Being tested
Patient Reported Outcomes Surveys, Clinical Assessments, Biomechanical and Neuromuscular Assessments, Conventional MRI
Keywords
football, athlete

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Patient Reported Outcomes SurveysOther

    Also called HaOS, FASH

    • Oslo Sports Trauma Research Center Hamstring Injury Screening Questionnaire (HaOS) at baseline
    • Functional Assessment Scale for Acute Hamstring Injuries (FASH) within 7 days of injury and within 7 days of return to sport (RTS)
  • Clinical AssessmentsOther

    • Injury History at baseline, within 7 days of injury, within 7 days of RTS
    • Pain and Function Assessments within 7 days of injury, within 7 days of RTS
  • Biomechanical and Neuromuscular AssessmentsOther

    • Eccentric Strength measure at baseline and within 7 days of RTS
    • Sprinting Biomechanics at baseline and within 7 days of RTS
  • Conventional MRIDevice

    Also called Magnetic Resonance Imaging (MRI)

    at baseline, within 7 days of injury, and within 7 days of RTS

Study groups in NCT05343052
Study groupRoleWhat they receive
Student AthleteStudent-athlete rostered on the varsity football team of participating institutions between 5/1/2022-6/30/2025 (study period)
Receives: Other: Patient Reported Outcomes Surveys; Other: Clinical Assessments; Other: Biomechanical and Neuromuscular Assessments; Device: Conventional MRI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Aim 1: Initial Hamstring Strain Injury (HSI)

    The outcome will be occurrence of an index HSI, measured at the athlete level. Athlete characteristics will be used to develop the quantitative HAMIR index to predict those at greatest risk of HSI. This aim will also identify potential future targets for injury risk mitigation and prophylactic strategies.

    HSI defined as an acute injury to the posterior thigh that limits full, unrestricted sports participation and includes two or more of the following symptoms: palpable pain along the hamstring muscles, posterior thigh pain without radicular symptoms, weakness and/or pain with resisted knee flexion, and pain with running.

    Measured: up to 3 years

  2. Aim 2: Recurrent Hamstring Strain Injury (HSI)

    The outcome will be the occurrence of a recurrent, or secondary, HSI measured at the athlete level. The investigators will use quantification of injury metrics (e.g., volume of initial edema and volume, shape and location of long-term scar) and incorporate these into the analytics framework to develop a new "re-injury" HAMIR index. Similar to Aim 1, this aim will identify potential future targets for re-injury risk mitigation and prophylactic approaches.

    Re-injury will be defined as an acute HSI that occurs to either limb within 6 months of an index HSI.

    Measured: up to 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Apr 2022
  2. Study start25 Apr 2022
  3. Primary completion5 Jun 2025
  4. Study completion5 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
699 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05343052
Sponsor's protocol ID
2021-1420
Other IDs
A536130, Protocol Version 6/15/2023
Status last verified
Jun 2025
First submitted
15 Apr 2022
Last updated
11 Jun 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Wilwand M, VanderAkker J, Guymon I, Mortensen BB, Johnson AW. Normalized Eccentric Hamstring Strength in Collegiate American Football: Position-Based Norms and Longitudinal Patterns. J Strength Cond Res. 2026 Jul 27. doi: 10.1519/JSC.0000000000005632. Online ahead of print.

    PubMed 42506958
  • Hulm S, Lin YC, Maniar N, Timmins RG, Hickey JT, Heiderscheit BC, Blemker SS, Opar DA. Impact of Prior Hamstring Strain Injury on Muscle Morphology and Sprinting Biomechanics in Collegiate American Football Athletes. Scand J Med Sci Sports. 2026 Jun;36(6):e70317. doi: 10.1111/sms.70317.

    PubMed 42261806
  • Heiderscheit BC, Blemker SS, Opar D, Stiffler-Joachim MR, Bedi A, Hart J, Mortensen B, Kliethermes SA; HAMIR Study Group. The development of a HAMstring InjuRy (HAMIR) index to mitigate injury risk through innovative imaging, biomechanics, and data analytics: protocol for an observational cohort study. BMC Sports Sci Med Rehabil. 2022 Jul 15;14(1):128. doi: 10.1186/s13102-022-00520-3.

    PubMed 35841053

Questions about this trial

What is this clinical trial studying?

An observational study of Hamstring Injury, run by University of Wisconsin, Madison at 5 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Aim 1: Initial Hamstring Strain Injury (HSI) (time frame: up to 3 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05343052, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jun 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in